Membrane changes associated with secretion occur in the absence of external calcium or after treatment with cytoskeletal disrupting agents.
Stafford
S V
SV
Department of Biochemistry, School of Medical Sciences, Bristol University, U.K.
Schofield
J G
JG
D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D002417:Cattle; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D003599:Cytoskeleton / Q000187:drug effects* / Q000378:metabolism; D004705:Endocytosis; D005089:Exocytosis; D010903:Pituitary Gland, Anterior / Q000166:cytology; D011726:Pyridinium Compounds / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
C073804:FM1 43; D011726:Pyridinium Compounds; D000644:Quaternary Ammonium Compounds; D013973:Thyrotropin-Releasing Hormone; D002118:Calcium